RAF kinase modulators and methods of use
    8.
    发明授权
    RAF kinase modulators and methods of use 失效
    RAF激酶调节剂和使用方法

    公开(公告)号:US08557830B2

    公开(公告)日:2013-10-15

    申请号:US12663504

    申请日:2008-06-05

    CPC分类号: C07D487/04 C07D473/00

    摘要: The present invention comprises a new class of compounds capable of modulating the activity of Raf kinase and, accordingly, useful for treatment of Raf kinase mediated diseases, including melanomas, tumors and other cancer-related conditions. The compounds have a general Formula (I) wherein each of A1, A2, A3, A4, A5, A6, A7, A8, A9, bond B, X, rings Z1 and Z2, R1 and R3 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of Raf kinase mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.

    摘要翻译: 本发明包括能够调节Raf激酶活性的新一类化合物,因此可用于治疗Raf激酶介导的疾病,包括黑素瘤,肿瘤和其它癌症相关病症。 化合物具有通式(I),其中A1,A2,A3,A4,A5,A6,A7,A8,A9,键合B,X,环Z1和Z2中的每一个,R1和R3如本文所定义。 本发明还包括药物组合物,用于治疗Raf激酶介导的疾病的方法,以及可用于制备本发明化合物的中间体和方法。